Daratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC). Academic Article uri icon

Overview

publication date

  • December 6, 2023

Research

keywords

  • Amyloidosis
  • Immunoglobulin Light-chain Amyloidosis

Identity

Scopus Document Identifier

  • 85185107761

Digital Object Identifier (DOI)

  • 10.1080/10428194.2023.2290468

PubMed ID

  • 38054823

Additional Document Info

volume

  • 65

issue

  • 3